XBIT
XBIT
NASDAQ · Biotechnology

Xbiotech Inc

$2.37
+0.07 (+3.04%)
As of Feb 8, 2:14 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 51.54M 48.92M 53.08M
Net Income -6,374,638 -6,659,114 -5,888,081
EPS
Profit Margin -12.4% -13.6% -11.1%
Rev Growth +3.4% -7.2% +0.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 34.70M 43.16M 36.51M
Total Equity 56.50M 61.66M 62.33M
D/E Ratio 0.61 0.70 0.59
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -7,191,271 -7,364,625 -7,497,793
Free Cash Flow -8,326,283 -5,338,476 -7,416,749